Maven Securities LTD - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Maven Securities LTD ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$329,184
-87.6%
400
-89.2%
0.00%
-90.0%
Q2 2023$2,659,317
+709.1%
3,700
+825.0%
0.04%
+471.4%
Q1 2023$328,668
-8.9%
400
-20.0%
0.01%
-12.5%
Q4 2022$360,745
-83.1%
500
-83.9%
0.01%
-79.5%
Q3 2022$2,136,000
+22.3%
3,100
+24.0%
0.04%
-36.1%
Q1 2022$1,746,000
+2.4%
2,500
-7.4%
0.06%
+24.5%
Q4 2021$1,705,000
+156.0%
2,700
+145.5%
0.05%
+133.3%
Q3 2021$666,000
-63.9%
1,100
-66.7%
0.02%
-71.6%
Q2 2021$1,843,000
+224.5%
3,300
+175.0%
0.07%
+196.0%
Q1 2021$568,000
-33.3%
1,200
-20.0%
0.02%
-64.3%
Q3 2020$851,000
-9.0%
1,5000.0%0.07%
+9.4%
Q2 2020$935,0001,5000.06%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q3 2021
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 72,600$42,916,0000.05%
JANE STREET GROUP, LLC 74,600$44,098,0000.02%
GROUP ONE TRADING, L.P. 11,800$6,975,0000.01%
HRT FINANCIAL LP 700$413,0000.01%
Allianz Asset Management GmbH 1,500$887,0000.00%
JPMORGAN CHASE & CO 3,100$1,833,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders